newsfilter
← Latest News
GlobeNewswire·

Organogenesis Announces Initiation of Biologics License Application for ReNu®

CANTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for